US 8173360
Cell death inhibitor
granted A61KA61K31/00A61K31/5415
Quick answer
US patent 8173360 (Cell death inhibitor) held by Takeda Pharmaceutical Company Limited expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/00, A61K31/5415, A61P, A61P1/00